Clinical Trial Update: Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase [NA]

View source ↗

Summary

The NEAM UG3 Phase trial evaluating neurodevelopmental effects of antiseizure medications has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Stanford University | Conditions: Epilepsy | NA | Status: WITHDRAWN